Asia Pacific & Australia

Cook Islands looks into producing medicinal cannabis itself

Published

2 years ago

February 3, 2023

admin

Radio NZ reports

The Cook Islands could start growing its own cannabis following the country voting in favour of it being allowed for medicinal use.

A legally non-binding referendum on medicinal cannabis was held in August 2022 alongside the Cook Islands general election.

Sixty-two percent of respondents voted “yes” to the question: “Should we review our cannabis laws to allow for research and medicinal use?”

The Government has since created a committee to look into rules, regulations and availability for medicinal cannabis.

Committee chair Tingika Elikana said the country might need to change its laws to allow cannabis to be manufactured.

“If the opportunity is cheaper for us to manufacture our own to treat those with ailments in the country, then we might have to go down that road and encourage people to get that opportunity,” Elikana said.

“If we’re going to go down the road of manufacturing our own medicinal cannabis, then we might have to look at the issue of possession, because you don’t want to catch everybody who are legally entitled to possess because of being involved in the manufacturing of cannabis medicine in the Cook Islands.”

Elikana said the Cook Islands may allocate manufacturing licences or allow people to grow a certain amount for personal use.

https://www.rnz.co.nz/international/pacific-news/483490/cook-islands-looks-into-producing-medicinal-cannabis-itself

Source link

Asia Pacific & Australia

It All Turned A Bit Bogan At Aussie Medical Cannabis Symposium

Published

5 days ago

March 7, 2025

admin

Thanks to Hemp Gazette for spotting this – I have to admit I missed it and unsurprisingly nobody made me aware of it The Linked in Post from the organisers Some Comments

Source link

Asia Pacific & Australia

A shortage of prescribed medical cannabis supply has led to Australian patients being left stranded, according to the Legalise Cannabis Queensland Party (LCQP).

Published

2 months ago

January 6, 2025

admin

Just about sums up what wrong with medical cannabis supply in Australia if the LCQP assertions are true.

There are a million reasons why this is happening and msot of it is due to bad govt policy and greed on the part of some suppliers who know that they aren’t just supplying to a “medical” market.

Source: https://lismoreapp.com.au/NewsStory/australian-medical-cannabis-patients-face-ongoing-product-shortages/677783b6bcd792002e21893f

A shortage of prescribed medical cannabis supply has led to Australian patients being left stranded, according to the Legalise Cannabis Queensland Party (LCQP).

The disruption to vital medication for those who rely on it for chronic conditions, pain and other medical issues is doing patient harm, says patient advocate and Secretary of the LCQP Suzette Luyken.

“This isn’t just an inconvenience; it is doing harm to patients,” said Suzette Luyken, patient advocate and Secretary of the Legalise Cannabis Queensland Party.

“Before Christmas, supply chains were closing for extended periods, and those with psychiatric disabilities were badly affected. Depressions deepen over this season, and the results can be devastating for those who suffer from PTSD and depression. Imagine if this were insulin or heart medication—it would be a national scandal.”

Medical cannabis was legalised in Australia in 2016, offering hope to patients with conditions often resistant to conventional therapies. However, the reality has been far less promising. Supply chain disruptions, inadequate stock and poor planning have left pharmacies unable to fill prescriptions, forcing patients to endure the consequences.

“For many patients, the fallout has been severe. The interruption of care has left many struggling to manage their conditions effectively. Patients must endure debilitating symptoms; go back on to heavy-duty pharmaceuticals, or seek out product from the black market.”

The crisis has sparked urgent calls for action from both government agencies and the corporate cannabis industry. Key demands from patients and advocacy groups include:

1. Improved supply chain transparency and planning.

2. Emergency stock reserves to prevent shortages.

3. Greater accountability from manufacturers and distributors.

“Australia has excelled in many areas of healthcare, but when it comes to medical cannabis, we are letting our patients down,” said Suzette Luyken. “It’s time for regulators, manufacturers, and distributors to address these issues with the urgency they deserve.”

Southside Chempro owner Kyle Wood told the Lismore App he doesn’t think there is an inherent problem with the supply of medical cannabis.

“Medical cannabis has a conservative shelf life, so when it is imported into Australia, it has about six months to be distributed and used.

“The pharmaceutical companies have to anticipate what the supply will be in advance. With a conservative shelf life, this can leave them losing a lot of money, which they don’t want to do.

“It’s fine for the big-name brands who don’t have supply problems, but the smaller, boutique growers can have problems with the next grow crop. The bio-equivalence will never be the same, meaning the flower varies from crop to crop.”

The Australian medical cannabis industry is still too young to cover domestic supply, so overseas companies are needed to fill the gap.

Federal Government legislation also prohibits substituting between products, which causes supply chain issues.

Kyle said that supply chains can get caught up, and there can be a shortage for a month or two.

Source link